Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
AGMB
AgomAb Therapeutics NV
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$9.08
· 2026-10-09
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
RECENT INSIDER TRADES
2026-10-09
· Epstein David R
(Director)
· BUY
2026-10-07
· Epstein David R
(Director)
· BUY
2026-10-07
· Kemula Pierre Thadee Victor
(Chief Financial Officer)
· BUY
2026-10-07
· Knotnerus Tim Jasper
(Chief Executive Officer)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
34
Shares held
25,955,482
Value
$336.74M
Percent of shares outstanding
75.97%
As of quarter end
2026-06-30
RECENT NEWS
AgomAb Therapeutics NV (AGMB) Discusses Open-Label Extension Results of Phase IIa STENOVA Study in Fibrosing Crohn's Disease Transcript
AgomAb Therapeutics develops fibrosis treatment
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
AgomAb Therapeutics NV (AGMB) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit